Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amarin Corp Ads (AMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,389,535
  • Shares Outstanding, K 322,920
  • Annual Sales, $ 181,100 K
  • Annual Income, $ -67,870 K
  • 36-Month Beta 0.65
  • Price/Sales 29.76
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.10
  • Number of Estimates 3
  • High Estimate -0.09
  • Low Estimate -0.10
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.00 +0.37%
on 12/14/18
19.75 -18.68%
on 11/26/18
-0.06 (-0.37%)
since 11/14/18
3-Month
2.65 +506.04%
on 09/18/18
23.33 -31.16%
on 11/06/18
+13.16 (+453.79%)
since 09/14/18
52-Week
2.35 +583.40%
on 07/31/18
23.33 -31.16%
on 11/06/18
+12.78 (+389.63%)
since 12/14/17

Most Recent Stories

More News
BK Technologies Declares Quarterly Dividend of $0.02 per Share

WEST MELBOURNE, FL / ACCESSWIRE / December 7, 2018 / BK Technologies, Inc. (NYSE: BKTI) today announced that today its Board of Directors declared a quarterly dividend of $0.02 per share of the Company's...

IIPR : 52.11 (+0.70%)
AAPL : 165.48 (-3.20%)
TX : 28.33 (-1.22%)
EFR.TO : 4.68 (-2.70%)
CIIX : 0.5800 (+0.35%)
ITRO : 1.0000 (unch)
CNDGF : 0.3000 (-27.48%)
ZC.VN : 0.220 (unch)
PKTEF : 0.2046 (+4.92%)
CRON : 11.28 (-0.88%)
VFC : 75.15 (-1.40%)
ACBFF : 8.6900 (-12.80%)
CVSI : 4.8100 (+2.01%)
COUP : 64.53 (-1.77%)
Y.TO : 5.76 (-2.21%)
GRUB : 79.20 (-0.52%)
MDR : 7.12 (-6.19%)
ESK.VN : 0.080 (-20.00%)
EA : 80.16 (-0.87%)
CLSK : 2.5300 (-8.00%)
BABA : 149.00 (-1.64%)
MO : 52.73 (-2.21%)
XXMMF : 0.2711 (+5.36%)
AEM : 38.80 (-3.05%)
SING : 0.0162 (-1.22%)
EW : 160.13 (-2.32%)
DATA : 128.88 (-1.50%)
EIX : 59.64 (+0.18%)
XIM.VN : 0.280 (-1.75%)
ATVI : 47.75 (-1.57%)
HTHT : 29.90 (-2.54%)
SSRM : 11.49 (-1.54%)
JRSH : 6.01 (+0.17%)
ZTMUF : 0.1860 (+2.20%)
MAR : 107.66 (-1.09%)
EXE.TO : 6.60 (-0.60%)
GBT.TO : 13.86 (-0.57%)
NBEV : 5.94 (+0.85%)
AVGO : 254.83 (-1.34%)
ORRP : 0.2250 (-5.06%)
DIIBF : 11.9409 (-3.78%)
FDIT : 0.0150 (+7.14%)
CMCM : 6.92 (+3.75%)
KLGDF : 10.5858 (+1.11%)
SHOP : 140.17 (-12.97%)
ESKYF : 0.0842 (-0.12%)
APOG : 31.95 (-1.39%)
SIA.TO : 16.62 (+0.54%)
TSRO : 73.69 (-1.07%)
GE : 7.10 (-1.39%)
NKTR : 36.51 (-3.92%)
ACB : 5.86 (+2.63%)
TWLO : 91.62 (-4.53%)
BKTI : 3.47 (-3.61%)
GLUU : 7.87 (+1.68%)
KR : 29.55 (-0.71%)
MGI : 1.88 (-1.05%)
MKL : 1,048.58 (-1.19%)
MOR : 27.70 (-0.89%)
OCLN : 0.0014 (unch)
IDTI : 48.03 (-0.08%)
AMRN : 16.06 (-3.77%)
APHA : 5.60 (+7.07%)
APTI : 37.84 (+0.03%)
L.TO : 60.70 (-2.22%)
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

AMRN : 16.06 (-3.77%)
Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know

Amarin (AMRN) closed at $17.67 in the latest trading session, marking a -1.83% move from the prior day.

AMRN : 16.06 (-3.77%)
Cardax Names Former Amarin Head of Development Paresh N. Soni, MD, PhD, to lead Clinical and Regulatory Strategy

Cardax, Inc. (OTCQB: CDXI) announced that Paresh N. Soni, M.D., Ph.D., the former Senior Vice President and Head of Development for Amarin Corporation, will join Cardax as Chief Clinical and Regulatory...

AMRN : 16.06 (-3.77%)
CDXI : 0.2000 (unch)
Market Trends Toward New Normal in Amarin, BioSpecifics Technologies, Cavco Industries, Iconix Brand Group, A-Mark Precious Metals, and Core-Mark Holding -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC (NASDAQ:AMRN),...

CVCO : 139.90 (-0.58%)
CORE : 24.76 (-5.57%)
AMRN : 16.06 (-3.77%)
ICON : 0.12 (-6.50%)
AMRK : 12.55 (-0.32%)
BSTC : 61.26 (+2.10%)
Amarin to Present at the Evercore ISI HealthCONx Conference

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's...

AMRN : 16.06 (-3.77%)
4 Stocks To Watch As Investors Dump Tech; Head To Healthcare

CORAL GABLES, FL / ACCESSWIRE / November 15, 2018 / This month Bank of America surveyed* 225 with $641 billion in assets under management, who said the most "crowded trade" is in tech stocks; in particular...

TDOC : 51.17 (-2.44%)
AMRN : 16.06 (-3.77%)
ARNA : 41.09 (-3.45%)
Key Pancreatic Cancer Therapy Developments Crucial in Combating World's Toughest Cancer

Financialnewsmedia.com News Commentary

AMRN : 16.06 (-3.77%)
LLY : 111.93 (-2.55%)
CLVS : 20.76 (-4.02%)
NVS : 87.39 (-1.14%)
MBRX : 1.26 (unch)
HLS Therapeutics Announces Q3 2018 Financial Results

HLS Therapeutics Inc. ("HLS" or the "Company") (TSX-V: HLS), a specialty pharmaceutical company specializing in Central Nervous System and Cardiovascular markets, announces its financial results for the...

HLS.VN : 14.990 (+0.33%)
AMRN : 16.06 (-3.77%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amarin Corporation - AMRN

Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation plc ("Amarin" or the "Company") . Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

AMRN : 16.06 (-3.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade AMRN with:

Business Summary

Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.

See More

Key Turning Points

2nd Resistance Point 17.02
1st Resistance Point 16.54
Last Price 16.06
1st Support Level 15.79
2nd Support Level 15.52

See More

52-Week High 23.33
Last Price 16.06
Fibonacci 61.8% 15.32
Fibonacci 50% 12.84
Fibonacci 38.2% 10.36
52-Week Low 2.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar